Eduardo Cazorla Amoros

Dr. Eduardo Cazorla Amoros

University Hospital of Torrevieja
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1999 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
AAAntonio Abad
Antonio Abad
EAEduardo Cazorla Amoros
Eduardo Cazorla Amoros
FRFernando Ruiz
Fernando Ruiz
IAIsmael Aznar
Ismael Aznar
EAEnrique Asins
Enrique Asins
JLJoaquin Llixiona
Joaquin Llixiona

5 February 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
EHEncarna Hernández
Encarna Hernández
MAMarcos Camacho Avila
Marcos Camacho Avila
César Leal-CostaCésar Leal-Costa
César Leal-Costa
MRMaría Ruzafa-Martínez
María Ruzafa-Martínez
Antonio Jesús Ramos-MorcilloAntonio Jesús Ramos-Morcillo
Antonio Jesús Ramos-Morcillo
José Luis Díaz-AgeaJosé Luis Díaz-Agea
José Luis Díaz-Agea
Clinical simulation in obstetrics has turned out to be a tool that can reduce the rate of perinatal morbidity and mortality. The objective of this study was to analyze the impact and evaluate the effects of training with high-fidelity simulation of obstetric emergencies on a multidisciplinary group. The quasi-experimental research study was structured in three phases: a first phase where the most important obstetric emergencies were determined, a second phase of design and development of the selected cases for simulation training, and a third and final phase where the abilities and satisfaction of the multidisciplinary team were analyzed. Three scenarios and their respective evaluation tools of obstetric emergencies were selected for simulation training: postpartum hemorrhage, shoulder dystocia, and breech delivery. The health professionals significantly improved their skills after training, and were highly satisfied with the simulation experience (p < 0.05). An inter-observer agreement between good and excellent reliability was obtained. Regarding conclusions, we can state that high-fidelity obstetric emergency simulation training improved the competencies of the health professionals.

15 May 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
MAMelanie Alonzo
Melanie Alonzo
EAEduardo Cazorla Amoros
Eduardo Cazorla Amoros
ECEsther Cánovas-Morales
Esther Cánovas-Morales
Juan Martinez-BlanchJuan Martinez-Blanch
Juan Martinez-Blanch
ECEmpar Chenoll
Empar Chenoll
VNVicente Navarro-López
Vicente Navarro-López
Understanding the characteristics of the vaginal microbiota of our patients allows us to carry out both a personalized therapeutic approach and a closer follow-up in those with microbiota susceptible to dysbiosis. This trial pursues the analysis of the vaginal microbiota of premenopausal women and its fluctuations within a four-week follow-up period. Vaginal samples of 76 fertile women were taken at a baseline visit and at a final visit (day 28 ± 5). To perform a phylogenetic study, we employed massive sequencing techniques to detect the 16S rRNA gene of the vaginal microbiota. The most prevalent vaginal microbial community was type I (34.87%), dominated by Lactobacillus crispatus. Vaginal microbial community types II (Lactobacillus gasseri) and V (Lactobacillus jensenii) were underrepresented in our population. When repeating the sampling process four weeks later, 75% of our patients maintained their initial bacterial community. In the follicular phase, the most recurrent microbiota was type III (Lactobacillus iners); in the periovulatory phase, types III and IV (microbial diversity); finally, in the luteal phase, the most frequent type was IV. The most prevalent vaginal bacterial community in our population was dominated by L. crispatus. The vaginal microbiota was resistant to changes in its bacterial community in 75% of our patients, even between consecutive menstrual cycles.

1 March 1997 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
EAEduardo Cazorla Amoros
Eduardo Cazorla Amoros
FRFernando Ruiz
Fernando Ruiz
AAAntonio Abad
Antonio Abad
JMJavier Monleon
Javier Monleon

1 January 2020 in The Application of Clinical Genetics
Verified
Journal Article
Open access
PDF file
MAMelanie Alonzo
Melanie Alonzo
EAEduardo Cazorla Amoros
Eduardo Cazorla Amoros
ECE Cánovas
E Cánovas
KAK Anniuk
K Anniuk
ACAe Cores
Ae Cores
ASAm Serrano
Am Serrano
The molybdenum cofactor deficiency is an autosomal recessive disease, characterized by rapidly progressive and severe neurological damage that mimics a hypoxic-ischemic encephalopathy due to the accumulation of toxic metabolites that cause rapid neurodegeneration after the delivery. It is eventually lethal, in a similar way to the rare isolated sulfite oxidase deficiency. This serious pathology usually causes death in the immediate neonatal period in the more severe variants. We report a case of two consecutive pregnancies with enlarged cisterna magna as the only prenatal pathological finding since 26 weeks of gestation (WG) and the subsequent death of the newborns in the first week after birth. After the second pregnancy, we reached the diagnosis of molybdenum cofactor deficiency due to MOCS1 gene mutation. According to the cases reported in the literature, this is the case with the earliest neuroimage prenatal findings.

1 November 2002 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
MMMariano Martin-Loeches
Mariano Martin-Loeches
RORafael M Ortı́
Rafael M Ortı́
EAEduardo Cazorla Amoros
Eduardo Cazorla Amoros
EAEnrique Asins
Enrique Asins
JLJoaquin Llixiona
Joaquin Llixiona